Professor Dennis Douroumis obtained his BSc in Chemistry and PhD from the Department of Pharmacy at Patras University in Greece. He worked as a postdoctoral fellow (2004) at the Friedrich–Schiller University of Jena, Department of Pharmacy for the development of parenteral formulations of antiepileptic drugs (Novartis Pharma, Basel). He also worked as a team leader (2005) in the development of nano-liposomal formulations and treatment of rheumatoid arthritis by applying photodynamic therapy (Biolitec Pharma GmbH.) Following this, he worked for Phoqus Pharmaceutical plc as a senior scientist at the product development department.

His research area focuses on the development of secondary continuous manufacturing by using hot melt extrusion (HME) of extrusion granulation coupled with PAT tools. His group is also involved in development of targeted anticancer drug delivery systems such as SLNs or NLCs produced by high-pressure homogenization. Finally he is actively involved in ink jetting and 3D printing technologies for the development of medical devices (e.g. microneedles, stents) and personalized medicines.

He has published more than 80 research articles, 7 book chapters and edited two books on HME and the delivery of water insoluble APIs. He has patented two proprietary technologies on the coating of transdermal microneedles and printing of drug eluting stents. Professor Douroumis has delivered keynote presentations at national and international conferences while his group presented several poster presentations.